TARA generates human relevant data to enable faster, safer, and more accurate development of new treatments. Our platform can reduce cost and increase the success of important new medicines reaching patients.
Cardiac Drug Discovery
We generate disease models from stem cells, enabling discovery of new medicines for heart conditions.
Cardiac Safety
Our cardiac tissue models reliably represent adult human hearts when applied to drug testing. We can accurately identify cardiovascular complications.
Precision Cardiology
Our platform can be used to create custom cardiac models tailored to a single person, allowing for personalized health and treatment.
TARA presents today at the WuXi Healthcare Forum in Shanghai. The forum brings together 1000+ innovators, entrepreneurs, clinicians, and investors from around the world that are shaping the future of healthcare.
READ MORENEW YORK, N.Y. (Newswire.com)—January 24, 2019—TARA Biosystems, Inc., a company offering physiologically relevant human “heart-on-a-chip” tissue models for cardiac risk assessment and drug discovery applications, today announced …
READ MORENew York – TARA Biosystems, Inc. a company offering “heart-on-a-chip” tissue models for drug discovery and risk assessment applications and Insilico Medicine, an artificial intelligence company developing end-to-end drug discovery pipelines for age-related diseases, announced today the launch …
READ MORE
